Hidradenitis Suppurativa (HS) Recruiting Phase 0 Trials for Secukinumab (DB09029)

Also known as: Hidradenitis Suppurativa / Hidradenitis / Sweat gland inflammation / Acne inversa

IndicationStatusPhase
DBCOND0054533 (Hidradenitis Suppurativa (HS))Recruiting0
clinicaltrials.gov IdentifierTitlePurposeDrugs